Showing results (511-520 of 525) with videos related to

Sort By:
Pageof 53
European Urology|July 13, 2016
Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302Johann S de Bono, Matthew R Smith, Fred Saad, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 2, 2023
RNA base editing therapy cures hearing loss induced by OTOF gene mutationYuanyuan Xue, Yong Tao, Xing Wang, et al.
European Urology|March 19, 2017
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302Matthew R Smith, Fred Saad, Dana E Rathkopf, et al.
Gigascience|August 12, 2025
A holistic genome dataset of bacteria and archaea of mangrove sedimentsShijun Pan, Huan Du, Ruiqi Zheng, et al.
Frontiers in Immunology|October 17, 2022
Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinomaLiangmin Fu, Jiahao Bao, Jinhui Li, et al.
Imeta|March 3, 2025
EGDB: A comprehensive multi-omics database for energy grasses and the epigenomic atlas of pearl milletLin Luo, Dongmei Lin, Jinhui Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2016
Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell CarcinomaQingyuan Huang, Kongjia Luo, Chun Chen, et al.
Nucleic Acids Research|June 16, 2021
Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP-HIPK2 axisXiaofeng Jin, Shi Qing, Qian Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2024
Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASUYoshitaka Honma, Nobuya Monden, Keisuke Yamazaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 resultsMichael J Morris, Arturo Molina, Eric J Small, et al.
Pageof 53